Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Equity-to-Asset : -4.29 (As of Jan. 2020)

Cotinga Pharmaceuticals Equity-to-Asset Chart

Cotinga Pharmaceuticals Annual Data
	Trend	Apr10	Apr11	Apr12	Apr13	Apr14	Apr15	Apr16	Apr17	Apr18	Apr19
Equity-to-Asset		Get a 7-Day Free Trial					0.44	0.57	0.15	-1.03	-1.92

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Equity-to-Asset	Get a 7-Day Free Trial															-1.05	-1.92	-2.82	-3.57	-4.29

Competitive Comparison of Cotinga Pharmaceuticals's Equity-to-Asset

For the Biotechnology subindustry, Cotinga Pharmaceuticals's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cotinga Pharmaceuticals's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's Equity-to-Asset falls into.

Cotinga Pharmaceuticals Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cotinga Pharmaceuticals's Equity to Asset Ratio for the fiscal year that ended in Apr. 2019 is calculated as

Cotinga Pharmaceuticals's Equity to Asset Ratio for the quarter that ended in Jan. 2020 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cotinga Pharmaceuticals  (OTCPK:COTQF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Cotinga Pharmaceuticals Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description